New Jersey 2022-2023 Regular Session

New Jersey Assembly Bill A5853

Introduced
12/11/23  

Caption

Appropriates $2.5 million to DOBI to reimburse joint insurance funds for COVID-19 surveillance testing.

Impact

The implementation of A5853 is intended to alleviate some financial strain on joint insurance funds that acted beyond the mandated federal guidelines to provide coverage for COVID-19 testing. By facilitating reimbursement to these funds, the bill supports the continued operation of health-related employers under pandemic conditions, ensuring that covered workers could maintain their employment while adhering to testing or vaccination policies. This legislative move may foster a more comprehensive response to healthcare issues emerging from the pandemic, though its effectiveness will depend on the uptake of the reimbursement process and the ongoing management of related funds.

Summary

Bill A5853 was introduced in the New Jersey legislature to address the financial burden faced by joint insurance funds that provided coverage for COVID-19 surveillance testing during a specified period. The bill proposes an appropriation of $2.5 million from the General Fund to the Department of Banking and Insurance (DOBI) specifically for reimbursing these funds. This is aimed at covering the costs incurred due to requirements for some employers to ensure proof of vaccination or conduct regular surveillance testing for their employees, particularly in healthcare and high-risk congregate settings, between August 6, 2021, and August 15, 2022.

Contention

While the bill appears to be largely supportive of joint insurance funds, it could be contentious among different stakeholders. Proponents argue that it provides necessary support to ensure that institutions tackling COVID-19 are not penalized for going above minimal requirements during a public health crisis. Conversely, there could be concerns raised about the appropriateness of using public funds for insurance reimbursements and the long-term financial implications for the state's budget. Some may question whether this sets a precedent for future appropriations related to health emergencies.

Companion Bills

No companion bills found.

Previously Filed As

NJ A4001

Appropriates $2.5 million to DOBI to reimburse joint insurance funds for COVID-19 surveillance testing.

NJ S2068

Establishes Health Care Workers COVID-19 Supplemental Benefits Program; appropriates $30 million.

NJ A3504

Establishes Health Care Workers COVID-19 Supplemental Benefits Program; appropriates $30 million.

NJ A5540

Establishes Health Care Workers COVID-19 Supplemental Benefits Program; appropriates $30 million.

NJ S3964

Establishes Health Care Workers COVID-19 Supplemental Benefits Program; appropriates $30 million.

NJ A1860

Increases Medicaid reimbursement rates for primary care services; appropriates $20 million.

NJ A4223

Increases Medicaid reimbursement rates for primary care services; appropriates $20 million.

NJ S2792

Increases Medicaid reimbursement rates for primary care services; appropriates $20 million.

NJ A5136

Establishes First Responders COVID-19 Supplemental Benefits Program; appropriates $20 million.

NJ A2018

Establishes First Responders COVID-19 Supplemental Benefits Program; appropriates $20 million.

Similar Bills

IL HB5834

$COURT OF CLAIMS-AWARDS

CA AB303

City of Ione: police department: reimbursement.

CA SB711

Taxation: federal conformity.

CA AB2504

Living Organ Donor Reimbursement Act.

CA SB225

School nutrition: guardian meal reimbursement.

NJ S4312

Modifies method of allocating State aid for providing auxiliary and remedial services to nonpublic school students.

CA AB1169

Health care facilities: interpreters.

CA AB997

Exoneration: mental health services.